Case 32 PageID 9

 

UNITED STATES DISTRICT COURT FOR THE.

 

 

SOUTHERN DISTRICT OF WEST VIRGINIA 
CHARLESTON GRAND JURY 2016-2 
FEBRUARY 13, 2018 SESSION FEB 

 

 

RORY L. PERRY CLERK
US. District Court
Southern District of West Vi?rginia

 

 

 

UNITED STATES OF AMERICA

 

v. CRIMINAL No. 59?? 209

21 U.S.C. 846

21 U.S.C. 856(a)(1)
JAMES H. BLUME, D.O. 21 U.S.C. 841(a)(1)
MARK T. RADCLIFFE 21 U.S.C. 841(b)(1)(C)
JOSHUA RADCLIFFE 18 U.S.C. 1956(h)
MICHAEL T. MORAN, M.D. 18 U.S.C. 2

D.O.
BRIAN GULLETT, D.O.
VERNON STANLEY, M.D.
MARK CLARKSON, D.O.
WILLIAM EARLEY, D.O.
PAUL W. BURKE, M.D.
ROSWELL TEMPEST LOWRX, M.D.
TERESA EMERSON, LNP

COUNT ONE
(Conspiracy to Distribute and Dispense Oxycodone)

The Grand Jury Charges:

1. From on or about November 2010, and continuing thrOugh
CH1 or about Lhnua 11, 2015, the Southern [metrict (If West
Virginia and eleewhere, the defendants JAMES H. BLUME, JR., D.O.,
MARK T. RADCLIFFE, JOSHUA RADCLIFFE, MICHAEIIT. MORAN, M.D., SANJAY
MEHTA, D.O., BRIAN GULLETT, D.O., VERNON STANLEY, M.D., MARK
CLARKSON, 0.0., WILLIAM EARLEY, D.O., PAUL W. BURKE, M.D., ROSWELL

TEMPEST LOWRY, M.D., and TERESA EMERSON, LNP, along with others

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 2 of 32 PagelD 10

known and unknown to the Grand Jury, did knowingly conspire with
each other to commit offenses in violation of 21 U.S.C.
84l(a)(l), that is, knowingly, intentionally, and unlawfully to
distribute Schedule II controlled substances, including a mixture
and substance containing a detectable amount of oxycodone, not for
legitimate medical purposes and outside the scope of professional
practice.
BACKGROUND

2. Beginning in or about November 2010, through in or about
June ll, 20l5, defendant JAMES H. BLUME, JR., D.O., owned Hitech
Opioid Pharmachovigilance Expertise Clinic, PLLC Clinic?),
a purported pain management clinic with locations in the Southern
District of West Virginia and elsewhere. In reality, HOPE Clinic
operated as a ?pill mill.? A pill mill is a physician?s office,
clinic, {Hf heal?a care facility tinn: routinely engages the
practice of prescribing and dispensing controlled substances
without a legitimate medical purpose and outside the scope of
professional practice.

3. On or about September 22, 2010, defendant BLUME entered
into a ?Physician Practice Management Agreement? with defendant
MARK T. RADCLIFFE. Essentially, under the terms of the agreement,
defendants BLUME and MARK T. RADCLIFFE agreed that defendant BLUME
would contract physicians for HOPE Clinic and defendant MARK T.

RADCLIFFE would serve as the rmactice manager of HOPE Clinic.

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 3 of 32 PagelD 11

Defendant MARK T. responsibilities under the terms of
the agreement included forming a limited liability company to run
the day~to~day operations of HOPE Clinic, hiring and supervising
non?medical employees, and often approving and directing financial
transactions on behalf of HOPE Clinic.

4. Defendant MARK T. RADCLIFFE owned and operated Patients,
Physicians, and Pharmacists Fighting Diversion, inc. 
which acted as the practice management company for HOPE Clinic.
purported mission was to ?protect pain care against the
diversion of pmescription narcotic pain medicine and help law
abiding patients.?

5. At all times relevant to this Indictment, operated
out of the same locations as HOPE Clinic. Part of the purported
mission. of was to :protect. pain Inanagement clinics with
?narcotics auditors.? Narcotics auditors allegedly were
professionals trained to protect ?from the dangers of drug abuse
and diversion by screening out higherisk patients that are prone
to abuse and trafficking of their narcotics medication.? Defendant
MARK T. RADCLIPPE typically hired former law enforcement officers
as narcotics auditors.

6. During the course of the conspiracy, defendants BLUME

and MARK T. RADCLIFFE opened the following HOPE Clinic locations:

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 4 of 32 PagelD_#: 12

 

Location Address

440
Charleston
Kanawha County, WV

Beaver July 2013 June 11, 2015 106 Lockheed Drive
Beaver
Raleigh County, WV

 

 

7. Defendants BLUME and MARK T. RADCLIFFE also owned,
operated, and/or were affiliated with HOPE Clinic locations in
Whitehall, West Virginia; Fishersviile and Mechanicsville,
Virginia; and 'Murfreesboro, Tennessee, during different times
between November 2010 and June 2015.

8. Defendant MARK T. son, defendant JOSHUA
RADCLIFFE, initially began employment through at the Beckley
HOPE Clinic as a receptionist and narcotics auditor in October
2010, then was eventually promoted to Clinic Manager. Effective
January 28, 2013, defendant MARK T. RADCLIEFE promoted defendant
JOSHUA RADCLIFFE to be the Director of Human Resources and the
Supervisor of the Beckley HOPE Clinic Manager.

9. At all times relevant to this Indictment, defendants
MARK T. RADCLIFFE and JOSHUA were not licensed medical
professionals and had no known formal medical education or

qualifications in the State of West Virginia or elsewhere.

13
ho

te Dates

lClanS 

oxima

Appr



to prescribe controlled

ize
Clinic
Locations

led 02/15/18 Page 5 of 32 PagelD 
Primary HOPE

defendants were licensed 

were author



a





1


.e

1



18?cr-00026 Document 4 
The following
an

Defendant

10.

Case 5
substances for legitimate medical purposes and in the usual course

of professional practice

worked at HOPE Cl

 

    

                           

      

Egg

 


?museum

?a

  

     

n\


 

new

A: 

swung; aw.
ww?i


.. ?w

1va 

$333? new
w?Wuumnueurm l.
ukum Weakenum? 

        

  

   
  

 

                          
  
    

                     

ubuwmm
?ame,? 
Wanda; awn,

         

Beckley
BeaVer

Ric

 

 

    



 

         
  

    

  

ic
in

for

 

imes

1n

 

2014
nurse

inic

Defendant
Defendant


7
I

mew



a

{mm
9,

?xwm?m'

October 2013

V,
?es



2



icense

HOPE Cl

who was at 
iCian.

April 2012 April

2014

4
1

2


b.






June 2015

I

  

     
        

     

license.


for

        
        

   

and November 2012


was a J.



nurSing

                          

I

   

LNP,



I

2014 through August practitioner

          

      

 

   

 

 



irginia

   

 

    





   

 

   

worked. at time Charleston. HOPE Cl

WV

      

   
          



  

   

a

        

DUISE

 

   

 

 

 
        

 

       

  

 

a

 

    

   

 

      
               

    

.:
eggs
as



 

 

gnfufaw
mug;
?cw?d

  

      

?yanks!


wens?

   

                        



a

$54
?page
53:.

     

any.
$2.3



  

    

tioner,
held

1

who
authorized. to jprescribe controlled. substances
as

Mehta

Vernon Stanley
Defendant ROSWELL TEMPEST LOWRY

Defendant TERESA. EMERSON

pract
from on or about May 20

worked





2

 

1
ion
1

it

William Earley

Sanjay R.
icense

 

legitimate medical purposes and within the scope of professional

a 

locat
was
EMERSON

 

   

 

practitioner
practice under the superv

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 6 of 32 PagelD 14

Wytheville, Virginia, starting in or about September 2014 through
June 12, 2015.
CONTROLLED SUBSTANCES - GENERAL ALLEGATIONS AND TERMINOLOGY

13. The Controlled Substances Act governs the manufacture,
distribution, dispensation.<xf controlled substances 111 the
United States. The Act and the Code of Federal Regulations contain
definitions relevant to this Indictment, some of which are set
forth below.

14. The term ?controlled substance? means a drug or other
substance, or immediate precursor, included in Schedule I, II,
'111, or IV, as designated by 21 U.S.C. 802(6) and the Code of
Federal Regulations.

15. The term ?Schedule means the drug or other substance
has a high potential for abuse, has a currently accepted medical
use with severe restrictions, and abuse the drug or cmher
substances may lead to severe or physical
dependence.

16. The term ?practitioner? means a medical doctor,
physician, or other individual licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which he or
she practices, to dispense controlled substances in the course of

professional practice.

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 7 of 32 PagelD 15

17. The Drug Enforcement Administration issues registration
numbers to qualifying practitioners, who are then authorized to
dispense Schedule II, IV, and controlled substances.

18. To be issued and maintain a DEA registration number, a
physician or non?physician must comply with all state laws
regarding the practice of medicine and the prescribing of
medication.

19. In Virginia, for a medical provider to
yhave prescribing authority, the provider must be under a written
agreement with a licensed physician who assumes responsibility for
all prescriptions issued under that agreement.

20. A practitioner violates the Controlled Substances Act
and the relevant Code Federal Regulation if he or she issues a
prescription for controlled substances not for legitimate medical
purposes and outside the scope of professional practice.

21. The West Virginia Board of Pharmacy maintains the West
Virginia Prescription Monitoring Program by centrally
collecting data regarding the prescribing and filling of Schedule
II, and EV controlled substances to deter the illegitimate
use of prescription controlled substances. A similar system is
maintained in Virginia, which is known as the Virginia Prescription
Monitoring Program in Kentucky, which is known as the
Kentucky All Schedule Prescription Electronic Reporting

and in Ohio, which is known as the Ohio Automated RX

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 8 of 32 PagelD 16

Reporting System. An individual report generated. by
these systems is typically referred to as a Prescription Monitoring
Profile.

22. The term ?doctor shopping? refers to the practice of a
patient visiting multiple practitioners to obtain multiple
prescriptions for controlled substances.

23. Oxycodone is a narcotic, opioid analgesic classified as
a Schedule II controlled substance. It is sold in generic form and
under brand names including OxyContin, Percocet, Roxicodone,
Roxicet, and Endocet. When legally prescribed for a legitimate
medical purpose, oxycodone is used to treat moderate to severe
pain. However, even if prescribed for a legitimate medical purpose
and even if taken in the prescribed amounts, oxycodone can cause
physical and dependence.

24. Oxycodone and other Schedule II drugs have a high
potential for abuse and can be crushed and snorted, or dissolved
and injected to get an immediate high. This abuse could lead to
addiction, overdose, and, in some cases, death. At all times
relevant to this indictment, demand for oxycodone grew to epidemic
proportions in many parts of the United States, including Southern
West Virginia and Western Virginia, where drug dealers sold pills

containing oxycodone for $1 per milligram or more.

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 9 of 32 PagelD 17

MANNER AND MEANS OF THE CONSPIRACY
It was part of the conspiracy that:

25. Defendants BLUME and MARK T. RADCLIFFE Operated HOPE
Clinic as a cash?based business that prescribed oxycodone and other
Schedule II controlled substances to customers. Defendants BLUME
and MARK T. RADCLIFFE devised a scheme under which HOPE Clinic did
not bill customers insurance companies, did not require a physician
referral or substantive medical records from its customers, and
discouraged practitioners from referring customers for other type
of jpain?relieving' therapies such; as physical therapy, massage
therapy, or interventional pain management procedures. Even though
defendants BLUME and MARK T. RADCLIFFE held out HOPE Clinic as
specializing in the treatment of pain management, they knowingly
contracted the services of medical professionals with no
background or specialized training in pain management, including
defendants MORAN, MEHTA, GULLETT, STANLEY, CLARKSON, EARLEY,
BURKE, LOWRY, and EMERSON.

26. Defendants MORAN, MEHTA, GULLETT, STANLEY, CLARKSON,
EARLEY, BURKE, LOWRY, and EMERSON, executed defendants BLUME and
MARK TB scheme prescribing oxycodone anui other
Schedule ll controlled substances not for legitimate medical
purposes and outside the scope of professional practice in the

following non?exhaustive ways:

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 10 of 32 PageID 18

Consistently conducting cursory, incomplete,
inadequate, or no medical examination of
customers;

Failing to verify customers? medical
complaints prior to prescribing oxycodone and
other Schedule II controlled substances;

Providing large amounts of Schedule II
prescription medications to customers that
they knew to be and had a reasonable cause to
believe, were drug addicts, including
customers whom the practitioner did not
examine in person before issuing that customer
a prescription for a controlled substance;

Prescribing oxycodone and other Schedule II
controlled substances to customers who
admitted buying or receiving controlled
substances illegally;

PresCribing oxycodone and other Schedule II
controlled substances to customers whose drug
screens showed use of illicit controlled
substances or non?use of prescribed controlled
substances; and

Prescribing oxycodone and other Schedule II
controlled substances to customers even though
the customer?s Prescription Monitoring
Profile showed evidence of doctor shopping.

27. Although HOPE Clinic provided customers with

prescriptions for highly?addictive controlled substances,
oxycodone, practitioners, including defendants MORAN,
GULLETT, STANLEY, CLARKSON, EARLEY, BURKE, LOWRY, and
routinely:

a. Failed.to conduct sufficient dialogue with

customers regarding treatment options
risks and benefits of such treatments;

10

such as

MEHTA,

EMERSON

the
and

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 11 of 32 PageID 19

b. Failed. to adjust pain therapy to the
individual medical needs of the customers (if
needs existed);

c. Refrained from prescribing alternative
treatments, including physical therapy,
massage therapy, and interventional pain
management procedures; and

d. Failed to counsel customers as to the proper
usage and risks associated with the
inappropriate combinations of medications.

28. Defendants MARK T. RADCLIFFE, JOSHUA RADCLIFFE, and
employees gave medical direction to practitioners within
HOPE Clinic including directions on how often practitioners were
required to examine a customer, whether to reduce a customer?s
medications and the extent of the reduction for' failed drug
screens, and how long the practitioners should spend examining
each customer.

29. Defendant MARK T. RADCLIFFE and JOSHUA RADCLIFFE
instructed medical practitioners at HOPE Clinic to provide
customers with prescriptions for Schedule II controlled
substances, sometimes in direct contrast with the practitioners?
clinical opinions.

30. After a customer was denied controlled substance
prescriptions by one practitioner at HOPE Clinic, defendants MARK

T. RADCLIFFE and JOSHUA RADCLIFFE routingely reassigned the

customer to a different HOPE Clinic practitioner at a different

ll

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 12 of 32 PageID 20
i
HOPE Clinic location to ensure the customer received a prescription
and continued paying HOPE Clinic and fees.

31. The Beckley, Beaver, Charleston, and wytheville HOPE
Clinics had large numbers of customer visits per day with typically
only one practitioner working at each location. Some HOPE Clinic
locations, including Beaver and Charleston, averaged sixty?five or
more customers 53 day? during ea ten?hour' workdayr with. only' one
practitioner working and on some days had an excess of one hundred
customers per day per practitioner.

32. During the course of the conspiracy, pharmacies began to
refuse to fill prescriptions from practitioners of the HOPE Clinic.
In order to facilitate customers getting their prescriptions for
Schedule II controlled substances filled, defendant MARK T.
RADCLIFFE created a pharmacy liason program within and would
direct customers to a pharmacy willing to fill their prescriptions.

33. Defendants BLUME and MARK T. RADCLIFFE used unlicensed
narcotics auditors with no medical education to take_
customers? blood pressure, pulse,,and medical history. Narcotics
auditors also wrote out prescriptions without a practitioner?s
order and preprinted prescriptions for the practitioner?s
signature basd on the prescription received by the customer at the
last month?s visit.

34. Defendant BLUME MARK if. RADCLIFFE ciui not hire

additional medical professionals such as nurses, physician

12

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 13 of 32 PageID 21

assistants, or other medical professionals because hiring
additional medical personal would ?cut into the doctor?s profit.?

35. Under defendant BLUME and. MARKS T. plan,
defendants MORAN, MEHTA, GULLETT, STANLEY, CLARKSON, EARLEY,
BURKE, LOWRY, and EMERSON consistently prescribed oxycodone and
other opiate medications to customers, such as morphine,
oxymorphone, methadone, and fentanyl, not for a legitimate medical
purpose and outside the scope of professional practice.

36. Defendants STANLEY, GULLETT, EARLEY, LOWRY, and BURKE
prescribed in a one?year period from September 10, 2013, through
September 9, 2014, approximately 2,130 oxycodone?based pills to
customer P.H.

37. Defendants MORAN, prescribed from February 27,
2013, through August 12, 2014, approximately 2,205 oxycodonembased
pills and 660 morphine pills to customer J.L.C.

38. Defendants STANLEY, GULLETT, EARLEY, and CLARKSON
prescribed from. November 6, 2012, through, November 20, 2013,
approximately 2,250 oxycodone?based pills to customer 3.6.

39. Defendants CLARKSON, EMERSON, and other practitioners
known to the Grand Jury, prescribed in a one?year period beginning
March 6, 2014, approximately 1,610 oxycodonembased pills to

customer J.M.B.

13

Case Document 4 Filed 02/15/18 Page 14 of 32 PageID 22

HOPE FINANCIAL INFORMATION
40. Defendants BLUME and MARK T. RADCLIFFE charged in?state'
customers at least $275 for an initial appointment and at least
$160 for each subsequent visit. Each out?of?state customer paid at
least $330 for an initial visit and at least $185 for each
subsequent visit.
41. As detailed$ below, defendants BLUME and MARK T.

RADCLIFFE operated HOPE Clinic as a predominately cash business.

 

 

 

Total Customer Total Credit
. . Total Cash Cash
Year Payments Received oun Received Card Amount Percenta 
i From All Clinics Received 

       

$7,412,581.69 $6,577,088.94 $835,492.75

$3,375,309.91 $2,928,961.89 $446,348.02

 

42. During the operation of HDPE Clinic, defendant BLUME
controlled HOPE Clinic bank accounts at First Century Bank 
Account ?4625?) and Branch Banking Trust Bank Account 
1559?). Defendant MARK T. controlled bank accounts
at First Community Bank Account and Branch Banking
Trust Bank Account w1524?). The cash received from
customers of HOPE Clinic was deposited into the HOPE Clinic and
accounts. Defendant BLUME also paid Defendant MARK T.
RADCLIFFE various amounts for defendant MARK T. RACLIFFE

and services as practice manager of HOPE Clinic. Defendant

14

Case Document 4 Filed 02/15/18 Page 15 of 32 PageID 23

MARK T. RADCLIFFE deposited these payments from defendant BLUME
into FCB Account ~9268 and Account -1524.

43. ?Defendants BLUME and MARK T. RADCLIFFE paid bonuses to
practitioners, including defendants MORAN, MEHTA, GULLETT,
STANLEY, CLARKSON, EARLEY, BURKE, and LOWRY, based on the profit
of HOPE Clinic, which was directly tied to the number of customers
who visited each HOPE Clinic daily.

44. The bonus structure established by defendants BLUME and
MARK T. encouraged and rewarded practitioners, including
defendants MORAN, MEHTA, GULLETT, STANLEY, CLARKSON, EARLEY,
BURKE, and LOWRY, to prescribe Schedule II prescription pain
medications to customers who otherwise snowed signs of abuse or
diversion, at times in direct contravention of HOPE Clinic and
policies; to keep customers returning to the HOPE Clinic by
prescribing Schedule II controlled substances; and to move as many
customers as possible through HOPE Clinic each day without
providing legitimate medical care.

45. From November 2010 through May 4, 2012, defendant BLUME
typically issued large, checks containing the
practitioners? bonuses and wages from his PCB Account ?4625 to a
physician staffing company that administered the contracts between
HOPE Clinic and the practitioners. The physician staffing company
in turn distributed the funds, through checks written on its bank

accounts, to the practitioners. Beginning in April 2012 through

15

Case Document 4 Filed 02/15/18 Page 16 of 32 PageID 24

September of 2014, defendant BLUME used his Account ?1559 to
issue the checks containing the practitioners? bonuses
and wages to the physician staffing company. From October 2014
through the end of the conspiracy, defendant BLUME used his 
Account ?1559 to issue the checks containing the
practitioners? bonuses directly to the practitioners.

46. Defendant MARK T. RADCLIFFE and his company, also
paid bonuses to employees, including defendant JOSHUA
RADCLIFFE, clinic managers and narcotics auditors. Defendant
MARK T. RADCLIFFE based the bonuses, depending on the employee?s
position, on the number of customers seen by each auditor, the
number of paying customers at each HOPE Clinic location, or the
total number of audits completed at each clinic. Defendant MARK T.
bonus structure encouraged and rewarded 
employees, including defendant JOSHUA RADCLIFFE, clinic managers
and narcotics auditors, to increase the number of customer visits,
to keep customers who were in violation of HOPE Clinic and 
policies, and to move as many customers as possible through HOPE
Clinic each day.

In violation of Title 21, United States Code, Section 846.

16

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 17 of 32 PageID 25

COUNT TWO
(Maintaining a Drug?Involved Premises)

l. Paragraphs 1 through 46 of Count One are incorporated
herein by reference.

2. Between in or about November 2010, through in or about
July 2013, in Beckley, Raleigh County, West Virginia, within the
Southern District of West Virginia, defendants JAMES H. BLUME,
JR., 0.0., and MARK T. RADCLIFFB, aided and abetted by each other,
knowingly and intentionally opened, rented, used, and maintained
office space at 404 Carriage Drive, Beckiey, West Virginia, 25801,
for the purpose of distributing' and. dispensing a1 mixture and
substance containing a detectable amount of oxycodone, a Schedule
II controlled substance, not for legitimate medical purposes and
outside the scope of professional practice.

In violation of Title 21, United States Code, Section

856(a)(1) and Title 18, United States Code, Section 2.

l7

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 18 of 32 PageID 26

COUNT THREE
(Maintaining a Drug?Involved Premises)

1. Paragraphs 1 through 46 of Count One are incorporated
herein by reference.

2. Between in or about December 2011, through in or about
February 26, 2015, in Charleston, Kanawha County, West Virginia,
within the Southern District of West Virginia, defendants JAMES H.
BLUME, JR., D.O., and MARK T. RADCLIFFE, aided and abetted by each
other, knowingly and intentionally opened, rented, used, and
maintained office space at 4407 MacCorkle Ave SE, Charleston, West
Virginia 25304, for the purpose of distributing and dispensing a
mixture and substance containing a detectable amount of oxycodone,
a Schedule II controlled substance, not for legitimate medical
purposes and outside the scope of professional practice.

In violation of Title 21, United States Code, Section

856(a)(1) and Title 18, United States Code, Section 2.

18

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 19 of 32 PageID 27

COUNT FOUR
(Maintaining a Premises)

1. Paragraphs 1 through 46 of Count One are incorporated
herein by reference.

2. Between in or about July 2013, through in or about June
2015, in Beaver, Raleigh County, West Virginia, within the Southern
District of West Virginia, defendants JAMES H. BLUME, JR., D.O.,
and MARK T. RADCLIFFE, aided and abetted by each other, knowingly
and intentionally opened, used, and maintained office space at 106
Lockheed Drive, Beaver, Raleigh County, West Virginia 25813, for
the purpose of distributing and dispensing a mixture and substance
containing a detectable amount of oxycodone, a Schedule II
controlled. substance, not for legitimate :medical purposes and
outside the scope of professional practice.

In violation of Title 21, United States Code, Section

856(a)(1) and Title 18, United States Code, Section 2.

19

28

led 02/15/18 Page 20 of 32 PageID 

18-cr-00026 Document4 Fi

Case 5

TWENTY-ONE

COUNTS FIVE
(Distribution of Controlled Substances)

at or near Beckley

ted below,

18

On or about each of the dates 1



trio

is

in the Southern 

is,

3.11

County, West Virg

lg

Rale

and Beaver,

the chart

ted in

is

the defendants 

inia and elsewhere,

irg

of West 



istributed an

and unlawfully 

11y,

1011a

1y, intent

ing

below know

ture

 

pensed, a mix

ibuted and dis

tr

1.8

and caused to be 

I



ispense



ing ea detectable amount of aa Schedule II

in

and substance conta

chart below, not for

listed in the

as

substance

controlled



10118.

1 purposes and outside the scope of profess



ica

legitimate med



practice.

CONTROLLED SUBSTANCE

 

DATE

CUSTOMER PRESCR19TIQN

th and Number

reng

(St

DEFENDANT

COUNT

ills)

of 

WRITTEN

         

            

    

 

        

 

                    

             
 

       

            

           


new, are?, BM.


3,



323m. 

.

   
 

Morphine Sulphate7gR
120
120
90
60

     

                   

         

         

  

                    

    

                        
 

               

   

        

   

       

 

     

   

      

 

                      

     

 

        

       
        

 

                                   

   
              
   

 

s. . New 
swam We. ?aw
2.: 
.53. ewe: W. 57.2.. ..,
lune?. 392.3% 
mid.? \xaqu} vine. 
32., ?me new .. 333,3?.
.m .55, m. 
3? .2: 
m; .. ?17mvnovm
Amused?, we?

mes. .,.mwwm, 
new?,

42?,?wi
354213,
325':
55:113.
f; ?5

         
 

 

         

 

      

         

     

      

. we,

                  

    


Esme: .33..

 

222?
we
,ww

Oxycodone 10 mg;

.f

     

      


It? paw,



 

             
      

  

            

   

    

   

    
   

Oxycodone 30 mg,
Oxycodone 30 mg,
Oxycodone 15 mg,
?QxyContin 10 mg,

. ?lm,

17,, 
.w ,v mm wire33:3

 

              

      

              

vs?,

1:

.33.

i

      

             
     

         

 

ex,



   

.
?We?

     


.3 Su 53

33,33

WV, 53,33.
fats?
?23,233

   




 

    

  

                       

. t3

      

 

 

 

08/14/2013
05/19/2015
07/02/2013
03/18/2014

                  

  

   

          

333.? ?.32
3. ?1 

                  

fez?

?31.53
..mnmm,w,wwm.u2w?

?Wm?

    



 

    

                                     
  

 

k: 
u. .25.. lieum?


                        

 

 

?ing.

 

   

      

    

 

mm:

           

 

   

         

D.L.

 

     



. 3..

5 He, 3.,

is??



 

              

keg-E

mm?,
mu: 


a

      

       

              




    



.

J.C.

         

        

 

J.L.C.

,.Lw La.
?r?m?rensxx?

                  
                              

    

  

., lM?y? .., .,
rant?:

  

   

:3 New?,

         

   

. 
. 
meanness, 

 

 

 

 

  

  
   

             

tumSANJAY MEHTA

  




               
    

$2.22

a nuvww ,wam,
?aw ?2&2 ms. .
. 

 

    

 

             
  

   

MICHAEL T.
MORAN

MEHTA
BREAN GULLETT

   

       

   

 

                  

 

322..
WV: 
..: ..,22233 .92,me
we. re? ., .2 

           

         

 

                      

. 
.VWSM 

 

 

 

 

 

  

                      

     

 

       

?xju??m?unxShim?,
,5 2.. . then. ?swims,

         

when,?



  

       

3:33- 

 

         

             

     

 

 

 

 

..

. New,

is? ., 
. 51%,
Waive, . 

      

       
  

      

3,3? 



 

     

 

335..


         

.. 

50

Oxycodone 17 mg,

12/02/2014

SANJAY MEHTA

 

20

29

led 02/15/18 Page 21 of 32 PageID 

18?cr-00026 Document4 Fi

Case 5

., ,1 4111?
1&1 1.1111,..w11, ,11.,11s,_

11 1111111111~$111u1w
.Amww .

1,1,wwm1w1mm11w
\11.,m1w1. ?.11

150
120
60

11111 ?mm? 1m" \1
11.111111 .111 1 1. 1
1 1.11., 11111 1.1
1.1 11111. 1.1.1111. 11 11 .1 
1 1111 11%.
11.1111 .1111 
111. 1.1111 1111 111.1 .

11.11111 11.. T11.

?111,111.
.51. 1.1.1..
11

dun:



.wux. .4 >1
.1111, 
1, 

1. 1 1
M111. 



w,

mum-11

Oxycodone 30 mg,
Oxycodone 15 mg,

.111 1111?

.111111111

1% 
M11111: 11m?.
\Uvrrz 1 n? 1 AW. 
up.

. 
11.1. .11. 11.1111.
him. 1.1.1211. 1 . 1

. 111.11.11.11

4
11.1

2

5
2

6



. 111nm. .1


351?

$111.

1x11?
.1 1.521.112.1111;
1,1111. 1.11111111111111Mn11111w211

,1N111111u1111111111111 

11.111211111111111 111.1111

Wavyrw

1
11111111111111.1111 11
1.111.111.3111?
.1111 
2
5.4.7.1..
. 11.111.112.5wn114.



?is

in

1!?!wa my."

?111.11.11.11 ..
1.1111 1. 1 in??

1 1111114. 1.11.. 

111w4a111r?u?12111N1 

. 1.111..

1111.. .1 111.111.1111.." /1.1 1 1

11 1.1.



.

1v.

:19.

.1111.
11
11.1.1.1 



.


1 3:15:

.4.


m:


11.1%
raw.

game-w
1.11.11.
42


11.111.111.111 ?114
1111.11.11? 111.111.1111.
. 1.11: 11 .


1241.1


1.11.1.1, 1.71.
1.011111 1.

12924:?

1.1.114. @111?.
$41.11. 11,111
gamma.

111M 





.1 1.
13% 11:11.

:31.

111.1. 
1711111111 .1 1.1111131 1
11111141111111.1w1Q11111
111111111
1 .111.

SANJAY MEHTA

1: $239 I

2121M 
1. {1 - 111
@111?

OXyContin 15 mg.


. 1
13








mi;

r?x

12.1w-

M11.11111,11w11
1113.111?. W111.

1111111111.?: 
,me W1. $411111



5511
13:1111 21

1 ..11111. .1 
..wu?f?bu
11
?New?.
111111111.

161

?1.2 
.3313. 791.11%:
.13.. 1. - 1
Sawing:

?Wk


m. . 1
.4111}.111.1..11 1111.111:
.

 

(:ng

 

United States Code, Section

Title 21,

in violation 0

All

841(a)(l).

21

30

led 02/15/18 Page 22 of 32 PageID 



SIXTY-SIX

at or? near

listed. below,

Southern

the

i



irginia,



West

County,

in

ted

is

the defendants 

elsewhere,

ia an

in

unlawfully

and

ionally,

tent

ll?l

knowingly,

distributed and

and caused. to be

I



detectable amount

ing a

in

the chart below,

in

ted

scope of

and outside the

CONTROLLED

DATE
PRESCRIPTION

SUBSTANCE
(Strength and
Number-of Pills)

CUSTOMER

WRITTEN

 

4.. 4.4.4 .444.,4.H4444z.4.

44 4.4.444,4,44 444.4,,

4.,444.4.ww
.444
4..
44.442

4.44 ?44.444424




.
.42.. .

.awwm. .2

. 

4..
44.9.42



,4

4R

..44 .444. 444 

.44. 

44.4.44. 4 
4 .. 
4.4,.wa 
4444 4 

.444, 
?444.444.4444, 
4.43.4444

MM.
44

03/25/2014

120

Oxycodone 10 mg,

120
Percdcet 7.5

mg/325,

4 ex.? 4
mm?a?





. 
442442.:

44.4 4 4

Rw. 

44.43
4 4.. 2



..4..

4.42.34.


ans



. ..-



.., 2.444 bee?ng
.4424.

:1

3.3.





5.2.4.42; .

m"
?mails?"-
ums. 

.2. 

4.24.24. ..

2%



Mummy.

. ..

4.4.2,

.44..-.

2.4.2444.

., 



in ..

u.

22442244. .2

6O
Percocet lO mg/325,
120

OXycodone l0 mg,

06/17/2014



in?rm.
2::523?2;


"2

$212,535.22





Sammie:


.

l?2

OXycodone 30 mg,

120

 

05/07/2014

S.B.

22

ispense

irg

ice.

COUNTS
(Distribution of Controlled Substances)

ture and substance conta

Kanawha
a mix

below

1 pract
DEFENDANT

Document4 



of West 
iona

chart

On. or about each. of the dates
lC

ibuted and 

tr

Case 5
tr

is
is

ispense

of a Schedule II controlled substance as lis
COUNT

Charleston,


the




 

not for legitimate inedical. purposes

profess

ski .44 44,44 

syml?? 

3? 
{2:9 1 .



K.

4444 .,24
.. 
. 

4:2?

Su?sm. .

.4 4..

.242.

4? 

.2254. ?Mmmn?mn 44..



44.421.94.24 ?.13
22,22,222

..1 main. Ara. 2 Mai






 

.22

Win42

W4 



.
44.44 2.24



4:3? w.
I 


.4.

WILLIAM E-ARLE-Y

47 2
1:

344,,
Meg?



22
w.


.2, .,,m44.4 

.x
.4




.m 2:22.22. .,


.. 4.442. 
4. 44

2 .442 .442


.. . .
..J.2. 2.4.2242?

em ..3442443 2.22?.


., .

Wm. 2.444.351 .

.. 22.222

322.6?:


BRIAN GULLETT
ROSWELL
TEMPEST LOWRY

$4

.32. .2




3: 
4. 

2
2:22.24




.4 22
.

$552

s- 


.222.? .e
.339?

?2.42.2?
.
4 

{a223



 

27

 

:31

CONTROLLED
SUBSTANCE
(Strength and
Number of Eills)

BREE

led 02/15/18 Page 23 of 32 PageID 
CUSTOMER PRESCRIPTION

18?cr-00026 Document 4 
DEFENDANT

Case 5
COUNT

 

?14,1- ?=22

- .5



L52
.5525 .




.4
m.


5
'3

6O

Percocet 10 mg/325



1:41:44

41413-554555: LL
1.5.445;
- 

. ., ..

.451




L. 5?s;
$0245.:
,wiLmi

Luvs 
111?,
.45?

?~35
5
1.
?50.
2'11?

22:540.







.

Oxycodone 30 mg,





953%










2:44;? ?gs-1,4555; -

LL 
2.59 

?x 42 4.55554?.

4 

?35: 
?2

2

E5,

3553555553?
L,

,5

.9.

..

?1,555?, 
L. 
54512541?

1.
LL


?a

Lg.5532"

OXyCodone 15 mg,

.
5

Law 4
2W4i?wm2
?2041252425 . .. 45 0.
.. 5 4?sz

as)
1:
x;

.15

.vcv.

4
30




?.5971- in .


1

02
.41

hang-wrung?! .-
LL

mm"

$4515.55 =5
xii->352 ELSE:
?12,3 3
130/43? -
a
- Mas,

mw-L

?1mm.

.2 L. 
35.9.} 


mew-?45W

:ims

mew-v.

L.
er?. 

4-5.. 
.zirr?



s? i??gififmw

mg?;



v? 

22.0%, - 5/



A

120

w. 21*?

is}: 

2054:?;
.

4w.?



5%
7g.?

S.

Percocet 10 mg/32

OXycodone 15 mg,
Oxycodone 30 mg,
120

Oxycodone 15 mg,

150
150

Morphine Sulphate

ER 15 mg,
Oxycodone 26 mg,

Oxycodene 30 mg,
OxyCodone 30 mg,
OXyeodonelS mg,

Oxycodone 15 mg,

mg,

?m 2L .
44.3, .. 2.2, 
- - . Egghemg?z?a? a; 
.2: ?4:15:55 
8511;?
Egg . 



?my

 



?@551025513133? - . - "0:23:45.? my?. 
Paw-i . m2. . - ?Mamma-
. - ?5.415 
.ng 5535.3;wg. 4 mm: 4 ?magnum?.-
-.. .525,? 4/ .mwam 4.1222154

. 










.4415; 
4444554532: 4 Li; if
.324.? NM.- 

mm
mm-




.2

5,

"rm







.11..
mm; .

7:1 . aw?nwi
. . . . . 
1 . 
123;? . 21m, Mung-1m .
. mus. - . - mm? -
.452? ?7 24,441.9444
?he a axkuw-?qmg;
v.4? .4 
. . 
?415.42%: ?avr?ygsxi

. a
$34 $25: M.
z? .

1a #33218: . 
5 50.52.: 
u!

04/23/201?

swf?a

<21

L-xax

.. 32404.5;
1? 2 

4.. '3?01' 44,-4-
?503.. 5; 




=54;

(5,5,2
1:04.501
.. . 44.1; .. 4,409,,
?4555? 22:55;
?4504?" mgr-5*
1 6 g;


-. a
?ea-Ra?m?g?mwv; 25 -L

g?zsz??i (4 s? 5 
1.: 355L244.-



xica

~21

?12/2014

WRITTEN

532
g,

My. 3:12:34Alli{gamma I TR . .- 214?
. 22322144, 45 34-? ?#21942; 

??2157
5,


?41?

619?

6

=44
:3

L:

:57!


5

07/01/2013
11/18/2013
08/27/2013
01/14/2014
05/07/2014


?s





.350453:23 - 
>35; 
. ..-.. vi .

(5,5,5 2:51. 



4 

Iii?

4?2;





33..


14:40,: .251?. - 1 55.31?: 44252:: . - . 
@132:stng - 
1255535512.; ?1 LLEEJgig/r?gf?f?ugc?g; . . - c; 
. 151.2411: 
1: - 0.1.1?552 ?554;;
2 ?10?3:55;, .. 05.43
. Magi . 5? :3 
3: 54:3?


21.0.

a:


>521?,
"w

 

4444:5411!

4,32.


432':



5


.2123



0:

.4

. 
-



 


.5 
era/2w; .

,5 iwx
$3,341.44? -. ms?:
xii-3i: . . 





..

?221,442.
?4
.. 

1%
L, 
?g?wm. 1..

122:; 1?2
4 
5%;24 20:42.01; 44* we, . .

.4: 71.14? W. . 2.1.

L1??~10??i?wmf - 

02413? *4 ms 

3?55 L.
2? 0 ?4%:an 

25.4.41 03.44.4114 2
52.41.30.?

2142 ?241205. La
lira. ?gamma? 525.122; 
@130 2:10:wa

.422424



'23

my?





4 4:
22.4







452.?? 1.;5050255532
mm. 1 

0.
v. Law?-
a
.

at


- A. 475554;.? 5
WW




mu?; . a 52??
Lzmawwgw .

84 .

Sm.?


. .11;
{301324244 

L413.)



2
(W


24%


a:

.



LC,

gag?


a

2i
?5
?Ham ~22?
5.52 

.. :02; 
?3


. 



Li.?
L:
4555

1,447..



?zz-$53;

qugm, ?23?

24703414., 555.?_ a
55.435314. 
30 33531

?a
m? . .
La?.



s.





4
mm?;

mm.
LG

BRIAN GULLETT

3 LL L95PAUL BURKE
PAUL BURKE

.
.



42%?ng

v. 2 - 
gfii?w?w - 5w $.31
s:

.21 mar;- - 

5.55:: .

5L.

VERNON STANLEY
WILLIAM EARLEY
BRIAN GULLETT
BRIAN GULLETT

-


.





23:ng



. 
?th

4,14 4L 1.,
avg-49mm5mm;



"21;
453),:
335.1% 5.31 n;
. - ?51.0? Mg: 45534.02?
1; 2i 2.3; way? .4an05; . mar? .
.3 Q4 . Q77, 
a, L. . 44244-55?: - 245%. 
- 2 . .244 L, 4.
454/,? .. (L1: 5L
4* 222%

1?1

 

9O

Oxycodone 30 mg,

23

N.J.



 

32
11$)

1

CONTROLLED
SUBSTANCE
(Strength and

Number of? 

DATE
PRESCRIPTION
WRITTEN

 

led 02/15/18 Page 24 of 32 PageID 

CUSTOMER

18?cr-00026 Document 4 
DEFENDANT

Case 5
COUNT

 

1.0.01
0.. 0 m, 

1.3% 13.10.00. 

60
60

201.413;

1~

. . .00 5 

11,0 . MC, .
00,4. 40100.0 0.0.2.1., is.

?10.,5001010. mm, 
0.41.52), 0. 00.00001.?

03.1..

.100 3,105..
.,
0.
0

.

12,0 .

011
1 1 000000
. 1.0.. .1.
11.10.1001
??11$wrw
10.0

0.01,. .1. . . 0.. 
0.0. in 010.110.10.030
. 00.000.00.001

?010000.000.101.100.021 

PerCocet 10 mg/325
60

.0001 $300
.1me 11, .11,
@1101

15 mg,
15 mg,

1.099
0%

.12.:

1.3

yr.

5;

Sulphate

1000.1;
11; 1%

in
in

1323?.
4
1?1

.,

108. #0030000?

01 .1.

 



 

lne

000.N140
1me

0.

00

$3





000W109.
0.5.0.1 .1.




. . Ema

w,

00.1. .

ERM30.mgr

180
Morphine Sulphate

Oxycodone 15 mg,
Oxycodone 20 mg,

OxyCodOne 15 mg,
120

Morph

ER 30 mg,

Oxycodone 15 mg,
120

120
MS Cont

MS Cont

120
MS Contin

OxycodOhe 15 mg,

 

0000.10; 0000.00. 
. .0007, . . .mwmw 
$011.03 1,101.1.10 .

Hr$03
0.000%


Jew

06/03/2014

.


c;
.m

.2, .01. .. .
meawawmm 
%mmh0?101.
$1101.10.

0
15:9:


.1


we:


a;
:23?

s1.

mm.

1

1. AW

11.110103. .. . .

. .012. 0.0011010?? .
if .01 

1:119

. 

0




am
. 0.0,


1W0, .0


0:1?


00.0.9.1 1.

A

.3436?


.

g}
.

.1. x. 
90.01.00.000?
11.. 
.
. .

. . 0.5.1. . .
.. . . 



07/24/2013

06/18/2014

08/13/2014

04/23/2014

. .
1 
4311M 


..

?0.3.000 .3102.
g; 113..


*1 3:3 
.01..
2145-

.



. 
10., 11.1.0.1. 30.0. 1 2%?03
. 
0.0. :1 0,0.
.1
00uaMmmauruwu?
0w}. 
?0mm . . gm
.4 \0 10va xx 5.2.000
0010.0.01.0.0, .
. .w .0171. F1 . . . 130000010001. 0,410 1

. . 003,2? $3,0040,00 .11.
0,006.00:


M:
.0.

,0 ,3

.00.,0100010 

. 

552'

1.1.10, 1:11.? .1 
in . 

x0 
0.15.0 0.00.;

10,00. ?if a
9: 02.10.. 61,.




as
00,0. .31. M.

.

WILLIAM E-ARLEY

000 
. 
.. 
.1. $0000 
.. 0.0.0.
. 0m. .00,



 

1.
1%

. 000330

ray

we?
~11

11:10

 



10,5535,
0 .

0

V0 


>7



0.106 

010%.
.
0.00.

.1




.0. 

01

13??

0.00.0

0 .
.0.
2101..101 .

 

100.11.?.
?11000?? .7.
.. 1 0 

000%??wm? 1.0.0.0110 

10.1.1.0
. .xw??wwm

0.0.0000.0.

it

. 



.11 35.1.1.1, .
1101.03.00. 01..
3.01.0
1.000000101300010 .0 . 
001.100.1222
00.1100000030040000100



.00

1.

0:5.
111%

1

1:1;

ROSWELL LOWRY
PAUL BURKE
VERNON STANLEY
WILLIAM EARLEY

TEMPE

711%?
0..

ma 01.1111002.30.0? . ?~00me 0.1m .. 
. .10 000.01, 11.10.00.000 .001Ea. any, 
. ..
.

1.1000. .
2300000.. 04,040?? 
5000.00 0.000 0010.010 . a 

.. .,wmm 

33

Sulphate
60

3

SUBSTANCE
lne

(Strength and
Number of Pills)

OXyoodone 30 mg,

120

CONTROLLED

Morph

2 33,3;333, . 3212272775552;

2.x. .m 


7 vyi?. 

6222;323:232? .,L'uf

LL We ?mime 

.27:?

37 ?Am 2 

.2. .2372772724 2&2,

27:77:27,277wa 2m;
.. Ly 

?13;
2- 22222222222 7, .
?33.725 . .
23d g. -. ?7 . . 
#:2377171;
2? ?2 72.77.: 5 ?we?

432.3% 2; 

77a.

?z
3,



48355:

OxycodOne 20 mg,


.
xx;

OXyoodone 15 mg,

180

. EU, :2
2223:7731.)
??323.22

?.me


7


332 
i

1211;; 5: 
iL/?k




mi),

1'27

La.
2

Li? . :22?


2

i

'32;

mew.?
i? 2:2?
73-22231?? r2.

LL

60
20 mg,

4:43:25. :c?g??fmgak


7mm 7.7.

2279/7 4%

$972253



23 333L232



in


7 47:72:; LL ?7


22222.
32222222

7e

ma
wee,

Oxycodone 30 mg,

1

32.27

w,.2m
was}?
222x



- 22

. - 7/ .

2757 . 7
$23

2? we. 7
{712.2,

mu
ext/2

Le:



20



:53, . .
-
{57:555.

Morphine Sulphate

oxycodOhe 30 mg,
Oxycodone 15 

OXyoodohe mg,
OxyCont

..
w-mLL-n. .2:

 

3%
=23:


4

75;" L.

 

~22

 

DATE
WRITTEN

03/20/2013

:,inwm. 7; Lamas? 7, 7.27.272 "7 I - ??792.
62175.}? 7?77 -
.747; .7.. ??-dii?rii??mi?" 
2 -
22;: earneaeszea-Lxgizah
if: 

5


.52:

22-2
E222


. 
2.122.. . -
732,77 

av?

m2
2

 



a.

7:77.12. :i 2

1.222.242}

2 2 21:22::

.. 
627Sr3?1?25m?7'ixe .L
. nut/2.2 223315 3772

,7

$232.3!



- 2571223?. 5,2 yum.

@314 . . . . . ?72-722 22L 

.uikh?i? ???533?3343?3?
.

22
22 IL.
.2222 2,2:
133% 37
LLaaxLugrL


2.

rim-mm
a:

10/30/2013' 

.L




. - 




.5742

2 
a L,
. 2
sags Fingi?g





.2sz 

2 7 27
272.22:
.2.

,2 w.

warm

,0

3% macewm





07/22/2013
03/21/2013
09/04/2014
07/10/2014

7% MM
7,227..wa -


727,7 

2.227522 527.227 42:21:; 3: 

gm.
7.72257.

?m



 

led 02/15/18 Page 25 of 32 PageID 

CUSTOMER PRESCRIPTION
L.M.

m2-2 

ngg?g?-E-mwn -





Egg-92:61!
.

52?:

7.222
m,



.7
722,.



37??
5
.L,


My.3.
2w.?
12221434"
72222

a?


.27..
-27. 72
3:2:52
,7

.12
M715
2277.
1.2:
221%:
men 2%

.mmeL

,722M737.





we.
27.7.2.
?72;

- 



.
2? 

M. 2
when?
m,

42.3.3.32.71.?.

we
L..-

a,
xm
92?7"

.

,1

 

18-cr-00026 Document 4 
DEFENDANT

VERNON STANLEY

7 . 2:2?
322737.222,
we \we?a




No;

,2

37.7.. @2273? 
2 W25 2 ?27%
2.2?2529732.7 (zit/7.

my,? 72: .77 mi, 

.

v.2,

- 3/2332 - -
ngo?w ?1 
isr??c? ?3k3217 47.772.77.742;-
- Leia.? 7 7 -

:7 
727 

Lg:

gmgh??wf

2215222 7

7*
3,2: mm?,
p?t?b?f?i?k?
$6321? 
a, 522223,,
My;

32mm?

 

.L:
I 
"?254522232232 7 

{313%

L..- 
?:52 2;

a

533Jim
wxw?


7,433?
mm,
m. 272.3%,
Lawn-r
..


as?,
2? 52222352553123; 

2% 37:17-32:42


7 2.2.7 72?:
Eiggaij?ifr?gg?w??i 1227.255?
f?

7,2,2.

.2,


3 ?m 2 
22 22:5 .2127
2%sz. 72:2.

7.7. 327:;




WM

x,

- 
2% 

L7,

25.12:,
2. 27

232222,!



ma?a/L




BRIAN GULLETT
VERNON STANLEY
VERNON STANLEY
PAUL BURKE
PAUL BURKE

 

Case 5

COUNT
55

 

 

{.227} 7 . - . 251:2.

7
was,? 1PT.

{353%,25 3., . . ?323331733?; 5 - (11 .Lwi?g: 

-, 2727:9337: 

7.


w,


72>,
4,2.
752227.7.

?77





m:
m? - 7232::

i






>22

 

7


 

Section

United States Code,

25

Title 21,

latlon 

in V10

All

841(a)(1).

Case Document 4 Filed 02/15/18 Page 26 of 32 PageID 34

COUNT 
(Distributing and Dispensing Causing Death)

On or about May 14, 2013, at or near Beckley, Raleigh County,
West Virginia, and within the Southern District of West Virginia,
defendant SANJAY MEHTA, D.O., knowingly, intentionally, and
unlawfully distributed and dispensed a quantity of oxycodone and
methadone, both Schedule II controlled substances, not for
legitimate medical purposes and outside the scope of professional
practice, which distribution resulted in the death of customer
T.P.G. from the subsequent use of the prescribed oxycodone.

In violation of Title 21,, United States Code, Section

841(a)(1) and 

26

Case Document 4 Filed 02/15/18 Page 27 of 32 PageID 35

COUNT 
(Distributing and DisPensing Causing Death)

On or about July 28, 2013, at or near Beaver, Raleigh County,
West Virginia, and within the Southern District of West Virginia,
defendant SANJAY MEHTA, D.O., knowingly, intentionally, and
unlawfully distributed and dispensed a quantity of oxycodone, a
Schedule II controlled. substance, not for legitimate medical
purposes and outside the scope of professional practice, which
distribution resulted. in the death. of customer J.B. from. the
subsequent use of the prescribed oxycodone.

In violation of Title 21, United States Code, Section

84l(a)(l) and 

27

Case 5:18-cr-00026 Document 4 Filed 02/15/18 Page 28 of 32 PageID 36

COUNT 
(Conspiracy to Money Launder)

l. Paragraphs 1 through 46 of Count One are incorporated
herein by reference.

2. From on or about November 2010, through June 2015, in
Beaver and Beckley, Raleigh County, and Charleston, Kanawha
County, West Virginia, in the Southern District of West Virginia
and elsewhere, defendants JAMES H. BLUME, JR., D.O., MARK 
RADCLIFFE, MICHAEL T. MORAN, M.D., SANJAY MEHTA, D.O., BRIAN
GULLETT, D.O., VERNON STANLEY, M.D., MARK CLARKSON, 9.0., WELLIAM
EARLEY, D.O., PAUL W. BURKE, M.D., and ROSWELL TEMPEST LOWRY, M.D.,
and others known and unknown to the Grand Jury, did knowingly
conspire with each other to commit offenses in violation of 18
U.S.C. that is knowingly to conduct and
attempt. to conduct financial. transactions affecting' interstate
commerce, which transactions involved the proceeds of specific
unlawful activities, with the intent to promote the carrying on of
the specified. unlawful activities, while knowing' the property
involved in the financial transactions represented the proceeds of
some form of unlawful activity.

3. The specified unlawful activities included the knowing,
intentional, and unlawful distribution and dispensing of
oxycodone, a Schedule II controlled substances, not for legitimate

medical purposes and outside the scope of professional practice,

28

Case Document 4 Filed 02/15/18. Page 29 of 32 PageID 37

in violation of 21 U.S.C. 84l(a)(l), and conspiracy to commit
that offense, in violation of 21 U.S.C. 846.

4. The defendants intended to promote the carrying on of
the specified unlawful activities through the payment and receipt
of bonuses to practitioners and employees, which encouraged
defendants to continue to prescribe Schedule II prescription pain
medications to customers who otherwise showed signs of abuse or
diversion, at times in direct contravention of HOPE Clinic and
policies; to keep onstomers returning to the HOPE Clinic by
prescribing Schedule II controlled substances; and to move as many!
customers as possible through HOPE Clinic each day without

providing legitimate medical care

In violation of Title 18, United States Code, Section 1956(h).

29

Case 5:18?cr?00026 Document 4 Filed 02/15/18 Page 30 of 32 PageID 38

NOTICE OF EORFEITURE

 

l. The allegations contained in Counts One through Sixty~
Nine of this Indictment are hereby realleged and incorporated by
reference for the purpose of alleging forfeitures pursuant to 21
U.S.C. 853 and 18 U.S.C. 982(a).

2. In accordance with 21 U.S.C. 853(a) and Rule 32.2(a)
of the Federal Rules of Criminal Procedure, and premised upon the
conviction of the defendants JAMES H. BLUME, JR., D.O., MARK T.
RADCLEFFE, JOSHUA RADCLIFFE, MICHAEL T. MORAN, M.D., SANJAY MEHTA,
D.O., BRIAN GULLETE, D.O., VERNON STANLEY, M.D., MARK CLARKSON,
0.0., WILLIAM EARLEY, 9.0., PAUL W. BURKE, M.D., ROSWELL TEMPEST
LOWRY, M.D., and TERESA EMERSON, LNP of a Violation of 21 U.S.C.
801 e: seg., the defendants shall forfeit to the United States
of America any property constituting, or derived from, any proceeds
obtained, directly or indirectly, as the result of such offenses
and.any property used, or intended to be used, in any manner or
part, to commit, or to facilitate the commission of, the offenses.

The United States intends to seek entry of a money judgment
against. the defendants for the gross proceeds involved. in or
traceable to property involved in the offenses set forth in Counts
One through Sixty~Eight of this Indictment.

3. In accordance with 18 U.S.C. 982(a) and Rule 32.2(a)
of the Federal Rules of Criminal Procedure, and premised upon the

conviction of defendants BLUME, MARK T. RADCLIFFE, MORAN, MEHTA,

30

Case Document 4 Filed 02/15/18 Page 31 of 32 PageID 39

GULLETT, STANLEY, CLARKSON, EARLEY, BURKE, and LOWRY of a violation
of Title 18, United States Code, Section 1956(h), as set forth in
Count Sixty?Nine of this Indictment, the defendants shall forfeit
to the United States any property, real or personal, involved in
the said offense, and any property traceable to property involved
in the offense, including but not limited to the following:

The United States will seek forfeiture as to each defendant
listed in the table below for the amount listed in the table, as
that sum in aggregate constitutes the gross proceeds deriVed by
the defendants from the conspiracy during the period alleged in

Count Sixty?Nine:

 

Defendant Amount

Mark Radcliffe $3,700,554.19
$695,990.00

?Vemon??stra?ng? $195,083.72-

 

4. If any of the property described above, as a result of
any act or omission of the defendants:

a. cannot be located. upon the exercise of due
diligence;

b. has been transferred or sold to, or deposited
with, a third party;

c. has been placed beyond the jurisdiction of the
court; 1

31

Case Document 4 Filed 02/15/18 Page 32 of 32 PageID 40

d. has been substantially diminished in value; or

e. has been commingled with other property which
cannot be divided without difficulty,

the United States of America shall be entitled to forfeiture of

substitute property pursuant to Title 21, United States Code,

Section 853(p).

By:

MICHAEL s. STUART 
United States Attorney

Mo. ICA D. coth-AN WW
As istant United States Attorney

rt

NMREDITH 53mg app/ms

Assistant United States Attorney

    

 

       

. . 

32